JOHN CRAIG THOMPSON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN CRAIG THOMPSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN CRAIG THOMPSON. JOHN CRAIG THOMPSON is President & CEO in Anthera Pharmaceuticals Inc ($ANTH) and President & COO in Anthera Pharmaceuticals Inc ($ANTH) and Chief Commercial Officer in Trius Therapeutics Inc ($TSRX) and Chief Operating Officer in TETRAPHASE PHARMACEUTICALS INC ($TTPH).
Latest Insider Trading Transactions of JOHN CRAIG THOMPSON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANTH, TTPH, TSRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 09 2018 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Option Exercise | A | 1.65 | 1,847,074 | 3,047,672 | 1,847,074 | |
| Sep 20 2017 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Buy | P | 1.32 | 8,550 | 11,286 | 19,848 | 11.3 K to 19.8 K (+75.68 %) |
| Sep 07 2017 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Buy | M | 1.43 | 10,400 | 14,893 | 17,590 | 7.2 K to 17.6 K (+144.65 %) |
| May 22 2017 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Option Exercise | A | 1.63 | 81,250 | 132,438 | 81,250 | |
| Mar 03 2017 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Option Exercise | A | 0.64 | 100,000 | 64,000 | 100,000 | |
| Dec 06 2016 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Option Exercise | A | 1.47 | 300,000 | 441,000 | 300,000 | |
| Jun 13 2016 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & COO | Option Exercise | A | 3.52 | 170,000 | 598,400 | 170,000 | |
| Sep 10 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Option Exercise | M | 14.45 | 10,000 | 144,500 | 157,501 | |
| Sep 10 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Sell | S | 44.08 | 10,000 | 440,800 | 343 | 10.3 K to 343 (-96.68 %) |
| Sep 10 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Buy | M | 14.45 | 10,000 | 144,500 | 10,343 | 343 to 10.3 K (+2,915.45 %) |
| Aug 07 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Option Exercise | M | 14.45 | 10,000 | 144,500 | 167,501 | |
| Aug 07 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Sell | S | 46.31 | 10,000 | 463,100 | 343 | 10.3 K to 343 (-96.68 %) |
| Aug 07 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Buy | M | 14.45 | 10,000 | 144,500 | 10,343 | 343 to 10.3 K (+2,915.45 %) |
| Jul 08 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Option Exercise | M | 14.45 | 10,000 | 144,500 | 177,501 | |
| Jul 08 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Sell | S | 47.91 | 10,000 | 479,100 | 343 | 10.3 K to 343 (-96.68 %) |
| Jul 08 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Buy | M | 14.45 | 10,000 | 144,500 | 10,343 | 343 to 10.3 K (+2,915.45 %) |
| Jun 16 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Option Exercise | M | 14.45 | 10,000 | 144,500 | 187,501 | |
| Jun 16 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Sell | S | 41.51 | 10,000 | 415,100 | 343 | 10.3 K to 343 (-96.68 %) |
| Jun 16 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Buy | M | 14.45 | 10,000 | 144,500 | 10,343 | 343 to 10.3 K (+2,915.45 %) |
| Jun 10 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Option Exercise | M | 14.45 | 22,499 | 325,111 | 197,501 | |
| Jun 10 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Sell | S | 43.00 | 10,637 | 457,391 | 343 | 11 K to 343 (-96.88 %) |
| Jun 10 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Sell | S | 43.50 | 11,862 | 515,997 | 10,980 | 22.8 K to 11 K (-51.93 %) |
| Jun 10 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Buy | M | 14.45 | 22,499 | 325,111 | 22,842 | 343 to 22.8 K (+6,559.48 %) |
| May 19 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Option Exercise | M | 14.45 | 30,000 | 433,500 | 220,000 | |
| May 19 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Sell | S | 39.63 | 30,000 | 1,188,900 | 343 | 30.3 K to 343 (-98.87 %) |
| May 19 2015 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Buy | M | 14.45 | 30,000 | 433,500 | 30,343 | 343 to 30.3 K (+8,746.36 %) |
| Mar 11 2013 | TSRX | Trius Therapeutics ... | THOMPSON JOHN CRAIG | Chief Commercial Of ... | Option Exercise | A | 6.13 | 125,000 | 766,250 | 125,000 | |
| Jan 11 2011 | TSRX | Trius Therapeutics ... | THOMPSON JOHN CRAIG | Chief Commercial Of ... | Option Exercise | A | 4.30 | 150,000 | 645,000 | 150,000 |
Page: 1